View Discovery

Clinical Pipeline

Trials for Market Approval Download PPT

Pre-Clinical (GLP)


TB Alliance, Institute of Materia Medica
TB Alliance, Janssen Research & Development, LLC
iM4TB - Innovative Medicines for Tuberculosis
University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF)
Microbiotix, Inc.

Phase 1


TB Alliance
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
GlaxoSmithKline
Otsuka Pharmaceutical Development & Commercialization, Inc.
Institute of Materia Medica

Phase 2


Sequella, Inc
Médecins Sans Frontières
The Aurum Institute NPC, Calibr, The Scripps Research Institute
Sequella, Inc
LegoChem
Nearmedic Plus LLC
NIAID, NIH, DHHS, Bill & Melinda Gates Foundation, EDCTP
CDC TBTC, NIAID, NIH, DHHS, Boston University
PanACEA, EDCTP, NIAID, NIH, DHHS, USAID
Weill Medical College of Cornell University